Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, its Phyto Extractions and Endgame Extracts brands are established with a distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. The Company partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market.

Employees

Sector

Pharmaceuticals

More about the company

Income Statement and Estimates

More financial data

Delayed Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		+26.32%	-

05-04	Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026	CI
04-29	Adastra Holdings Ltd. Announces Resignation of Paul Morgan as Director, Effective April 28, 2026	CI

Market Cap	1.32M 938K 813K 758K 697K 89.22M 1.33M 8.9M 3.49M 44.64M 3.52M 3.45M 148M	P/E 2023	-3.47x	P/E 2024	-0.1x
Enterprise Value	3.64M 2.6M 2.25M 2.1M 1.93M 247M 3.68M 24.63M 9.67M 124M 9.75M 9.54M 409M	EV / Sales 2023	655,990x	EV / Sales 2024	144,247x
Free-Float	98.73%	Yield 2023 *	-	Yield 2024	-

05-04	Adastra Holdings Ltd. Announces Director Changes, Effective April 30, 2026	CI
04-29	Adastra Holdings Ltd. Announces Resignation of Paul Morgan as Director, Effective April 28, 2026	CI
03-02	Adastra Holdings Ltd. Announces Resignation of Mark Qvist as Director, Effective February 28, 2026	CI
12-01	Adastra Holdings Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-14	An undisclosed buyer completed the acquisition of 1178562 B.C. Ltd. from Adastra Holdings Ltd..	CI
25-10-14	An undisclosed buyer completed the acquisition of Adastra Brands Inc. from Adastra Holdings Ltd..	CI
25-10-07	An undisclosed buyer agreed to acquire Adastra Brands Inc. from Adastra Holdings Ltd. for CAD 5000.	CI
25-10-07	An undisclosed buyer agreed to acquire Adastra Labs Holdings Ltd. from Adastra Holdings Ltd. for CAD 0.50 million.	CI
25-08-29	Adastra Holdings Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-30	Adastra Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-28	Adastra Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-27	Adastra Holdings Ltd. Auditor Raises 'Going Concern' Doubt	CI
25-03-03	Adastra Holdings Ltd. Appoints Mark Qvist as Member of Its Board of Directors	CI

05-12	Canadian Investment Regulatory Organization Trading Halt - XTRX	AQ
05-04	Adastra Holdings Ltd. Appoints New Director	NE
04-29	Adastra Holdings Announces Resignation of Director	NE
03-02	Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director	NE
25-10-15	Adastra Holdings Announces Completion of Sale of Subsidiaries	NE

Arrowstar Resources Ltd. Stock Toronto S.E.

Stocks

AWS

CA04281R2019

Pharmaceuticals

Valuation: Arrowstar Resources Ltd.

Latest news : Arrowstar Resources Ltd.

Press Releases: Arrowstar Resources Ltd.

Managers and Directors: Arrowstar Resources Ltd.

Alternative Medicine

Financials

Company Profile

Income Statement and Estimates

Director	Title	Age	Since
Jon Edwards BRD	Director/Board Member	-	2024-04-01
Calum Maschi BRD	Director/Board Member	-	2026-04-29

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARROWSTAR RESOURCES LTD.	-.--%	+26.32%	-	-	799K
YUNNAN BAIYAO GROUP CO.,LTD	-1.55%	-1.91%	-9.40%	-6.00%	13.45B
BEIJING TONGRENTANG CO., LTD	-2.68%	-3.09%	-32.09%	-54.39%	5.09B
DONG-E-E-JIAO CO., LTD.	-0.64%	+0.84%	+5.03%	+8.07%	5.13B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-2.08%	-1.67%	+0.49%	-33.25%	4.07B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.35%	-2.10%	-7.35%	-4.11%	3.7B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-0.61%	-2.60%	-2.67%	+4.67%	3.58B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.82%	-1.44%	-4.96%	+12.93%	3.48B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.89%	+0.19%	-14.80%	-23.12%	2.45B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-1.53%	-2.85%	-3.23%	+49.80%	1.87B
Average	-1.22%	-2.37%	-7.66%	-5.05%	4.76B
Weighted average by Cap.	-1.43%	-2.67%	-8.37%	-8.61%

	2023	2024
Net sales	22.22 15.85 13.73 12.8 11.77 1.51K 22.47 150.4 59.03 754.21 59.54 58.23 2.5K	24.84 17.72 15.35 14.31 13.16 1.69K 25.12 168.14 65.99 843.15 66.56 65.09 2.79K
Net income	-3.54M -2.53M -2.19M -2.04M -1.88M -240M -3.58M -23.99M -9.42M -120M -9.5M -9.29M -398M	-13.24M -9.44M -8.18M -7.62M -7.01M -898M -13.38M -89.58M -35.16M -449M -35.46M -34.68M -1.49B
Net Debt	2.26M 1.62M 1.4M 1.3M 1.2M 154M 2.29M 15.32M 6.01M 76.85M 6.07M 5.93M 255M	2.32M 1.66M 1.44M 1.34M 1.23M 158M 2.35M 15.73M 6.17M 78.88M 6.23M 6.09M 261M